STUB1 and COVID-19: While a direct causal relationship between CHIP and elevated cardiac biomarkers could not be firmly established, the data point toward a possible link, supporting the hypothesis that CHIP may worsen COVID-19 severity through immune dysregulation and could serve as a marker for personalized risk assessment [131].